More info…
CAMBRIDGE, Mass.—-Euthymics Bioscience, Inc., a clinical-stage company developing next-generation antidepressants, today announced the completion of a Series A financing — led by Novartis Venture Funds and Venture Investors for a total investment commitment of $24 million in milestone-conditioned tranches.
Euthymics Bioscience, Inc. Closes $24 Million Series A Financing and Completes Acquisition of DOV Pharmaceutical
July 24, 2010 By Leave a Comment
Anxiety and/or Depression Crisis Counselling Auckland
July 24, 2010 By Leave a Comment
More info…
Whether you have a diagnosed anxiety disorder (such as Obsessive Compulsive Disorder or Separation Anxiety Disorder) or are just feeling anxious or up